William G. Rice - 06 Jul 2022 Form 4 Insider Report for Aptose Biosciences Inc. (APTOF)

Role
Chair, President & CEO, Director
Signature
/s/ Janet Clennett as attorney-in-fact for William G. Rice
Issuer symbol
APTOF
Transactions as of
06 Jul 2022
Net transactions value
$0
Form type
4
Filing time
07 Jul 2022, 18:39:18 UTC
Previous filing
06 Jun 2022
Next filing
21 Sep 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APTO Performance Stock Options Award $0 +600,000 $0.000000 600,000 06 Jul 2022 Common Shares 600,000 $0.8100 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents performance stock options granted on July 6, 2022, which vest in tranches upon the achievement of specified performance events. Settlement of vested performance stock options will occur as soon as practicable following vesting. This grant is being reported voluntarily.